SURFACE EXPRESSION METHOD OF PEPTIDES P5 AND ANAL3 USING THE GENE ENCODING POLY-GAMMA-GLUTAMATE SYNTHETASE
    1.
    发明申请
    SURFACE EXPRESSION METHOD OF PEPTIDES P5 AND ANAL3 USING THE GENE ENCODING POLY-GAMMA-GLUTAMATE SYNTHETASE 有权
    使用基因编码多糖 - 谷氨酸合成酶的肽P5和ANAL3的表面表达方法

    公开(公告)号:US20070253935A1

    公开(公告)日:2007-11-01

    申请号:US11622158

    申请日:2007-01-11

    IPC分类号: A61K39/00 C12N1/21 C12N15/00

    CPC分类号: C07K14/32

    摘要: The present invention relates to a method for expressing each of peptide antibiotics P5 3 and Anal3 35 having amphiphilicity and showing antibacterial, antifungal and anticancer activities 61, 63, 65, 67, 69, 71, on the microbial surface, using a vector containing outer membrane protein genes (pgsBCA) that are derived from Bacillus sp. strains and involved in the synthesis of poly-gamma-glutamate. Moreover, the present invention relates to lactic acid-forming bacteria having each of the peptide antibiotics P5 15 and Anal3 43 expressed on their surface, and the use thereof. According to the present invention, the peptide antibiotics can be expressed on the surface of various microorganisms transformed with the surface expression vectors. The inventive method for the surface expression of the peptide antibiotics allows the peptide antibiotics to be mass-produced without a purification process. Thus, the inventive method has very high industrial applicability. Further, the present invention can be applied to other peptide antibiotics besides P5 3 and Anal3 35.

    摘要翻译: 本发明涉及使用载体表达在微生物表面上表现出具有两亲性的肽抗生素P 5 3和Anal 3 35的各种抗细菌,抗真菌和抗癌活性61,63,65,67,69,71的方法, 含有源自芽孢杆菌属的外膜蛋白基因(pgsBCA)。 菌株并参与了聚-γ-谷氨酸的合成。 此外,本发明涉及具有表面表达的肽抗生素P515和Anal343各自的乳酸形成细菌及其用途。 根据本发明,肽抗生素可以在用表面表达载体转化的各种微生物的表面上表达。 肽抗生素表面表达的本发明方法允许肽抗生素在没有纯化过程的情况下批量生产。 因此,本发明的方法具有非常高的工业实用性。 此外,除了P 5 3和Anal 3 35之外,本发明可以应用于其他肽抗生素。

    Surface expression method of peptides P5 and ANAL3 using the gene encoding poly-gamma-glutamate synthetase
    2.
    发明申请
    Surface expression method of peptides P5 and ANAL3 using the gene encoding poly-gamma-glutamate synthetase 失效
    使用编码聚-γ-谷氨酸合成酶的基因的肽P5和ANAL3的表达表达方法

    公开(公告)号:US20050191720A1

    公开(公告)日:2005-09-01

    申请号:US10789164

    申请日:2004-02-27

    CPC分类号: C07K14/32

    摘要: The present invention relates to a method for expressing each of peptide antibiotics P5 3 and Anal3 35 having amphiphilicity and showing antibacterial, antifungal and anticancer activities 61, 63, 65, 67, 69, 71, on the microbial surface, using a vector containing outer membrane protein genes (pgsBCA) that are derived from Bacillus sp. strains and involved in the synthesis of poly-gamma-glutamate. Moreover, the present invention relates to lactic acid-forming bacteria having each of the peptide antibiotics P5 15 and Anal3 43 expressed on their surface, and the use thereof. According to the present invention, the peptide antibiotics can be expressed on the surface of various microorganisms transformed with the surface expression vectors. The inventive method for the surface expression of the peptide antibiotics allows the peptide antibiotics to be mass-produced without a purification process. Thus, the inventive method has very high industrial applicability. Further, the present invention can be applied to other peptide antibiotics besides P5 3 and Anal3 35.

    摘要翻译: 本发明涉及在微生物表面上表达具有两亲性的肽抗生素P5 3和Anal335各自表现出抗菌,抗真菌,抗癌活性的方法, 来自芽孢杆菌属的膜蛋白基因(pgsBCA) 菌株并参与了聚-γ-谷氨酸的合成。 此外,本发明涉及在其表面表达的各肽抗生素P515和Anal343各自的乳酸形成细菌及其用途。 根据本发明,肽抗生素可以在用表面表达载体转化的各种微生物的表面上表达。 肽抗生素表面表达的本发明方法允许肽抗生素在没有纯化过程的情况下批量生产。 因此,本发明的方法具有非常高的工业实用性。 此外,本发明可以应用于除P5 3和Anal335之外的其它肽抗生素。

    Surface expression method of peptides P5 and Anal3 using the gene encoding poly-gamma-glutamate synthetase
    3.
    发明授权
    Surface expression method of peptides P5 and Anal3 using the gene encoding poly-gamma-glutamate synthetase 有权
    使用编码聚-γ-谷氨酸合成酶的基因的肽P5和Anal3的表面表达方法

    公开(公告)号:US08080402B2

    公开(公告)日:2011-12-20

    申请号:US11622158

    申请日:2007-01-11

    IPC分类号: C12N15/00 C12N1/21 A61K48/00

    CPC分类号: C07K14/32

    摘要: The present invention relates to a method for expressing each of peptide antibiotics P5 3 and Anal3 35 having amphiphilicity and showing antibacterial, antifungal and anticancer activities 61, 63, 65, 67, 69, 71, on the microbial surface, using a vector containing outer membrane protein genes (pgsBCA) that are derived from Bacillus sp. strains and involved in the synthesis of poly-gamma-glutamate. Moreover, the present invention relates to lactic acid-forming bacteria having each of the peptide antibiotics P5 15 and Anal3 43 expressed on their surface, and the use thereof. According to the present invention, the peptide antibiotics can be expressed on the surface of various microorganisms transformed with the surface expression vectors. The inventive method for the surface expression of the peptide antibiotics allows the peptide antibiotics to be mass-produced without a purification process. Thus, the inventive method has very high industrial applicability. Further, the present invention can be applied to other peptide antibiotics besides P5 3 and Anal 3 35.

    摘要翻译: 本发明涉及在微生物表面上表达具有两亲性的肽抗生素P5 3和Anal335各自表现出抗菌,抗真菌,抗癌活性的方法, 来自芽孢杆菌属的膜蛋白基因(pgsBCA) 菌株并参与了聚-γ-谷氨酸的合成。 此外,本发明涉及在其表面表达的各肽抗生素P515和Anal343各自的乳酸形成细菌及其用途。 根据本发明,肽抗生素可以在用表面表达载体转化的各种微生物的表面上表达。 肽抗生素表面表达的本发明方法允许肽抗生素在没有纯化过程的情况下批量生产。 因此,本发明的方法具有非常高的工业实用性。 此外,除了P5 3和Anal 3 35之外,本发明可以应用于其它肽抗生素。

    Surface expression method of peptides P5 and Anal3 using the gene encoding poly-gamma-glutamate synthetase
    4.
    发明授权
    Surface expression method of peptides P5 and Anal3 using the gene encoding poly-gamma-glutamate synthetase 失效
    使用编码聚-γ-谷氨酸合成酶的基因的肽P5和Anal3的表面表达方法

    公开(公告)号:US07255855B2

    公开(公告)日:2007-08-14

    申请号:US10789164

    申请日:2004-02-27

    IPC分类号: A01N63/00 C12N15/00 C12N1/20

    CPC分类号: C07K14/32

    摘要: The present invention relates to a method for expressing each of peptide antibiotics P5 3 and Ana13 35 having amphiphilicity and showing antibacterial, antifungal and anticancer activities 61, 63, 65, 67, 69, 71, on the microbial surface, using a vector containing outer membrane protein genes (pgsBCA) that are derived from Bacillus sp. strains and involved in the synthesis of poly-gamma-glutamate. Moreover, the present invention relates to lactic acid-forming bacteria having each of the peptide antibiotics P5 15 and Ana13 43 expressed on their surface, and the use thereof.According to the present invention, the peptide antibiotics can be expressed on the surface of various microorganisms transformed with the surface expression vectors. The inventive method for the surface expression of the peptide antibiotics allows the peptide antibiotics to be mass-produced without a purification process. Thus, the inventive method has very high industrial applicability. Further, the present invention can be applied to other peptide antibiotics besides P5 3 and Ana13 35.

    摘要翻译: 本发明涉及一种用于表达具有两亲性的肽抗生素P5 3和Ana1335的方法,并且在微生物表面上显示出抗菌,抗真菌和抗癌活性61,63,65,67,69,71,使用含有外源的载体 来自芽孢杆菌属的膜蛋白基因(pgsBCA) 菌株并参与了聚-γ-谷氨酸的合成。 此外,本发明涉及在其表面表达的各种肽抗生素P515和Ana1343的乳酸形成细菌及其用途。 根据本发明,肽抗生素可以在用表面表达载体转化的各种微生物的表面上表达。 肽抗生素表面表达的本发明方法允许肽抗生素在没有纯化过程的情况下批量生产。 因此,本发明的方法具有非常高的工业实用性。 此外,本发明可以应用于除P5 3和Ana1335之外的其它肽抗生素。

    Composition for Adjuvant Containing Poly-Gamma-Glutamic Acid
    8.
    发明申请
    Composition for Adjuvant Containing Poly-Gamma-Glutamic Acid 审中-公开
    含有多糖 - 谷氨酸的佐剂组合物

    公开(公告)号:US20080152615A1

    公开(公告)日:2008-06-26

    申请号:US11817021

    申请日:2005-12-06

    IPC分类号: A61K39/02 A61K39/12

    CPC分类号: A61K39/39 A61K2039/55516

    摘要: The present invention relates to a composition for an immunopotentiator (adjuvant) containing poly-gamma-glutamic acid and a composition for a vaccine containing the immunopotentiator, and more particularly, to an immunopotentiator containing poly-gamma-glutamic acid capable of enhancing antibody production rate by administering it to an animal together with antigen having low immunogenicity, and a composition for a vaccine containing the immunopotentiator and antigen. The inventive adjuvant has almost no toxicity and side effects, and show high antibody titer even when it is used with antigen having poor immunogenicity, so it can be used by adding to medical composition including preventive or curative vaccine for non-contagious chronic diseases as well as cancer, especially prostatic carcinoma, colon carcinoma, lung cancer, breast cancer, ovarian cancer, head and neck cancer, pudendum cancer, bladder cancer, brain tumor and glioma.

    摘要翻译: 本发明涉及含有聚-γ-谷氨酸的免疫增强剂(佐剂)组合物和含有免疫增强剂的疫苗组合物,更具体地说,涉及含有能够提高抗体产生率的聚-γ-谷氨酸的免疫增强剂 通过将其与抗免疫原性低的抗原一起施用于动物,以及含有免疫增强剂和抗原的疫苗组合物。 本发明的佐剂几乎没有毒副作用,即使与抗免疫原性差的抗原一起使用也显示出高的抗体效价,因此可以通过添加包含用于非传染性慢性疾病的预防或治疗性疫苗的医药组合物 作为癌症,特别是前列腺癌,结肠癌,肺癌,乳腺癌,卵巢癌,头颈癌,pudendum癌,膀胱癌,脑肿瘤和胶质瘤。